Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-15-117877
Filing Date
2015-04-02
Accepted
2015-04-02 16:09:03
Documents
7
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d846215d10ka.htm 10-K/A 66853
  Complete submission text file 0001193125-15-117877.txt   6462887

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT mbvx-20141231.xml EX-101.INS 702874
3 XBRL TAXONOMY EXTENSION SCHEMA mbvx-20141231.xsd EX-101.SCH 66231
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbvx-20141231_cal.xml EX-101.CAL 70611
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbvx-20141231_def.xml EX-101.DEF 310563
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbvx-20141231_lab.xml EX-101.LAB 534404
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbvx-20141231_pre.xml EX-101.PRE 428958
Mailing Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121
Business Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

EIN.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-31265 | Film No.: 15747590
SIC: 2834 Pharmaceutical Preparations